Analytical Data
-
基因名
MXRA5
- Application
-
别名
Adlican; Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NR99
-
表达区间
Pro2542~Phe2828
-
分子量
35kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MXRA5 (Matrix Remodeling Associated 5) is a relatively understudied protein that has garnered attention in recent years due to its potential roles in various biological processes, including tissue remodeling, inflammation, and immune response. Research indicates that MXRA5 is linked to the extracellular matrix (ECM) and may play a significant role in cellular interactions and signaling pathways. Dysregulation of MXRA5 has been implicated in several diseases, including cancer and autoimmune disorders, making it a focus of interest in biomedical research. The investigation of MXRA5 recombinant protein has become increasingly relevant for understanding its functional mechanisms and therapeutic potential. Moreover, the availability of recombinant MXRA5 can facilitate advanced studies in cellular biology and regenerative medicine, providing tools for elucidating its role in ECM dynamics and the pathogenesis of related diseases. Understanding the structure, function, and interactions of MXRA5 through recombinant techniques may pave the way for novel therapeutic strategies targeting ECM-related disorders. As such, ongoing research aims to characterize this protein further, shedding light on its significance in health and disease.
